Pediatric Multicenter Study of REPEL-CV
NCT00116233
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
Adhesions
Interventions
DEVICE:
REPEL-CV
Sponsor
SyntheMed